{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:09:27Z","timestamp":1790968167589,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ejogrb.2014.12.022","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T20:46:32Z","timestamp":1420836392000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors"],"prefix":"10.1016","volume":"186","author":[{"given":"Ines","family":"Vasconcelos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Braicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<278::AID-CNCR14>3.0.CO;2-T","article-title":"Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma","volume":"78","author":"Kennedy","year":"1996","journal-title":"Cancer"},{"issue":"71","key":"10.1016\/j.ejogrb.2014.12.022_bib0225","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/1097-0142(19930301)71:5<1810::AID-CNCR2820710516>3.0.CO;2-V","article-title":"A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982: a review of clinicopathologic features and treatment modalities","volume":"1","author":"Koern","year":"1993","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2014.12.022_bib0230","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1096::AID-CNCR13>3.0.CO;2-1","article-title":"Ovarian serous borderline tumors with invasive peritoneal implants","volume":"82","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ejogrb.2014.12.022_bib0235","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO;2-W","article-title":"Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis","volume":"62","author":"Bell","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2014.12.022_bib0240","series-title":"Histological typing of ovarian tumors. World Health Organization International Histological Classification of Tumors","author":"Scully","year":"1999"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0245","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/gyno.1993.1279","article-title":"Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors","volume":"51","author":"Trope","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2014.12.022_bib0250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0090-8258(91)90314-U","article-title":"ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study)","volume":"41","author":"Sutton","year":"1991","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2014.12.022_bib0255","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/sj.bjc.6603139","article-title":"Clinical outcome and risk factors for recurrence in borderline ovarian tumours","volume":"94","author":"Yokoyama","year":"2006","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0260","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1525-1438.2007.00864.x","article-title":"Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004","volume":"17","author":"Wong","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2014.12.022_bib0265","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1525-1438.2007.01051.x","article-title":"Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period","volume":"18","author":"Akeson","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0270","first-page":"155","article-title":"Clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years\u2019 experience in the Kinki District of Japan (1990\u20132006)","volume":"30","author":"Kokawa","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2014.12.022_bib0275","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ygyno.2008.12.034","article-title":"Surgical management of borderline ovarian tumors: the role of fertility-sparing surgery","volume":"113","author":"Park","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2014.12.022_bib0280","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/IGC.0b013e3182129842","article-title":"Fertility-sparing surgery for borderline ovarian tumors: oncologic safety and reproductive outcomes","volume":"21","author":"Song","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2014.12.022_bib0285","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/PGP.0b013e3181fcf01a","article-title":"Mucinous tumor of low malignant potential (\u201cborderline\u201d or \u201catypical proliferative\u201d tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion","volume":"30","author":"Khunamornpong","year":"2011","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.ejogrb.2014.12.022_bib0290","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/IGC.0b013e31824b4076","article-title":"Prognosis in patients with serous and mucinous stage I borderline ovarian tumors","volume":"22","author":"Song","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1096-9098(199702)64:2<147::AID-JSO11>3.0.CO;2-3","article-title":"Clinical behavior of borderline ovarian tumors: a study of 150 cases","volume":"64","author":"Tamakoshi","year":"1997","journal-title":"J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejogrb.2014.12.022_bib0300","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejogrb.2014.12.022_bib0305","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/cncr.20098","article-title":"Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study","volume":"100","author":"Fauvet","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2014.12.022_bib0310","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2005.05.033","article-title":"Recurrence and prognostic factors in borderline ovarian tumors","volume":"98","author":"Ayhan","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejogrb.2009.04.031","article-title":"Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort","volume":"145","author":"Lenhard","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2014.12.022_bib0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynakologische Onkologie (AGO) Study Group","author":"du Bois","year":"2013","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2014.12.022_bib0325","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0090-8258(89)90622-7","article-title":"Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential","volume":"32","author":"Fort","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2014.12.022_bib0330","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/1097-0142(19920701)70:1<152::AID-CNCR2820700125>3.0.CO;2-6","article-title":"Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases","volume":"70","author":"de Nictolis","year":"1992","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0335","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ygyno.2008.03.019","article-title":"A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors","volume":"110","author":"Ren","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2014.12.022_bib0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jso.21416","article-title":"Borderline ovarian tumors and extended patient follow-up: an individual institution's experience","volume":"101","author":"Rettenmaier","year":"2010","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2014.12.022_bib0345","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2011.08.008","article-title":"Micropapillary pattern in serous borderline ovarian tumors: does it matter?","volume":"123","author":"Park","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2014.12.022_bib0350","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/1097-0142(19900201)65:3<578::AID-CNCR2820650332>3.0.CO;2-N","article-title":"Serous ovarian tumors of low malignant potential with peritoneal implants","volume":"65","author":"Gershenson","year":"1990","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ejogrb.2014.12.022_bib0355","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D","article-title":"Serous borderline tumors of the ovary with noninvasive peritoneal implants","volume":"83","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2014.12.022_bib0360","first-page":"451","article-title":"Cisplatin based combination chemotherapy in the treatment of stage III ovarian epithelial tumors of low malignant potential","volume":"12","author":"Yazigi","year":"1991","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2014.12.022_bib0365","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1006\/gyno.1995.9956","article-title":"Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential","volume":"59","author":"Barakat","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2014.12.022_bib0370","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00000478-199611000-00004","article-title":"Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases","volume":"20","author":"Seidman","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2014.12.022_bib0375","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000478-200104000-00001","article-title":"Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas","volume":"25","author":"Bell","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ejogrb.2014.12.022_bib0380","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/annonc\/mdg173","article-title":"Prognostic factors for patients with advanced stage serous borderline tumours of the ovary","volume":"14","author":"Morice","year":"2003","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2014.12.022_bib0385","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000213294.81154.95","article-title":"The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent","volume":"30","author":"Silva","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2014.12.022_bib0390","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2013.11.006","article-title":"Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants","volume":"132","author":"Leary","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2014.12.022_bib0395","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/416951","article-title":"The grim heritage of Lysenkoism: four personal accounts. IV. Difficult years in Soviet genetics","volume":"65","author":"Gershenson","year":"1990","journal-title":"Q Rev Biol"},{"issue":"6807","key":"10.1016\/j.ejogrb.2014.12.022_bib0400","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/bmj.303.6807.884","article-title":"Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials","volume":"303","author":"Advanced Ovarian Cancer Trialists Group","year":"1991","journal-title":"BMJ"},{"issue":"Suppl. 4","key":"10.1016\/j.ejogrb.2014.12.022_bib0405","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/annonc\/4.suppl_4.S83","article-title":"Advanced epithelial ovarian cancer: 1993 consensus statements","volume":"4","author":"Allen","year":"1993","journal-title":"Ann Oncol"},{"issue":"3 Pt 2","key":"10.1016\/j.ejogrb.2014.12.022_bib0410","first-page":"S1","article-title":"Consensus conference on ovarian cancer: screening, treatment, and follow-up","volume":"55","author":"Trimble","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"3 Pt 1","key":"10.1016\/j.ejogrb.2014.12.022_bib0415","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/gyno.2000.5926","article-title":"A critique of surgical cytoreduction in advanced ovarian cancer","volume":"78","author":"Covens","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2014.12.022_bib0420","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0425","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.113","article-title":"International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.12.022_bib0430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514006721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514006721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:32:50Z","timestamp":1759555970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514006721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":43,"alternative-id":["S0301211514006721"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.12.022","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}